193 related articles for article (PubMed ID: 12803011)
1. Medullary thyroid cancer.
Clayman GL; el-Baradie TS
Otolaryngol Clin North Am; 2003 Feb; 36(1):91-105. PubMed ID: 12803011
[TBL] [Abstract][Full Text] [Related]
2. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
3. Medullary thyroid carcinoma: recent advances and management update.
Marsh DJ; Learoyd DL; Robinson BG
Thyroid; 1995 Oct; 5(5):407-24. PubMed ID: 8563482
[TBL] [Abstract][Full Text] [Related]
4. Current management of medullary thyroid cancer.
Sippel RS; Kunnimalaiyaan M; Chen H
Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of medullary thyroid cancer.
Modigliani E; Franc B; Niccoli-sire P
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):631-49. PubMed ID: 11289739
[TBL] [Abstract][Full Text] [Related]
6. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
7. Medullary thyroid carcinoma: state of the art.
Favia G; Iacobone M
G Chir; 2005; 26(11-12):405-9. PubMed ID: 16472416
[TBL] [Abstract][Full Text] [Related]
8. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
[TBL] [Abstract][Full Text] [Related]
9. Novel point mutation in exon 10 of the RET proto-oncogene in a family with medullary thyroid carcinoma.
Oriola J; Páramo C; Halperin I; García-Mayor RV; Rivera-Fillat F
Am J Med Genet; 1998 Jul; 78(3):271-3. PubMed ID: 9677065
[TBL] [Abstract][Full Text] [Related]
10. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
11. Medullary thyroid carcinoma. Genetic screening and prophylactic thyroidectomies.
Bergant D; Hocevar M
Acta Chir Iugosl; 2003; 50(3):121-4. PubMed ID: 15179767
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
Kambouris M; Jackson CE; Feldman GL
Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
[TBL] [Abstract][Full Text] [Related]
13. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.
Zedenius J; Larsson C; Bergholm U; Bovée J; Svensson A; Hallengren B; Grimelius L; Bäckdahl M; Weber G; Wallin G
J Clin Endocrinol Metab; 1995 Oct; 80(10):3088-90. PubMed ID: 7559902
[TBL] [Abstract][Full Text] [Related]
14. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Luo Y; Pasini B; Höppener JW; van Amstel HK; Romeo G
Nature; 1994 Jan; 367(6461):375-6. PubMed ID: 7906866
[TBL] [Abstract][Full Text] [Related]
15. [Medullary carcinoma of the thyroid: diagnosis and therapy].
Giuffrida D; Ferraù F; Bordonaro R; Mattina M; Priolo D; Aiello RA; Cordio S; Motta S; Failla G
Clin Ter; 2000; 151(1):29-35. PubMed ID: 10822879
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of RET proto-oncogene in the diagnosis of hereditary-type medullary carcinoma of the thyroid. Correlation with surgical findings].
Carreño M; Girbés J; Malluguiza R; Serrano S; Matias-Guiu X; Tudela J; Alfayate R; Lagarda H
Acta Otorrinolaringol Esp; 2001; 52(1):57-63. PubMed ID: 11269881
[TBL] [Abstract][Full Text] [Related]
17. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
Fink M; Weinhüsel A; Niederle B; Haas OA
Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
[TBL] [Abstract][Full Text] [Related]
18. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
Marsh DJ; Mulligan LM; Eng C
Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
[TBL] [Abstract][Full Text] [Related]
19. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
Fitze G; Saeger HD; Roesner D; Schackert HK
Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary.
Klein I; Esik O; Homolya V; Szeri F; Váradi A
J Endocrinol; 2001 Sep; 170(3):661-6. PubMed ID: 11524247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
